Muhammad Shahid

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Mild Cognitive Impairment

Blood Brain Barrier

Top Venues

Drug design, development and therapy

International journal of molecular sciences

Naunyn-Schmiedeberg's archives of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

null Shagufta, Gowhar Ali, Salman Khan, Abdur Rasheed, Farah Deeba, Rahim Ullah, Muhammad Shahid, Haleema Ali, Rasool Khan, Najeebullah Shamezai, Naveed Sharif
Evaluation of the Ameliorative Potential of 3,5- bis (2-hydroxyethyl)-1,3,5-thiadiazinane-2-thione against Scopolamine-Induced Alzheimer's Disease. International journal of molecular sciences 25 (16) (2024)
null Shagufta, Gowhar Ali, Salman Khan, Abdur Rasheed, Farah Deeba, Rahim Ullah, Muhammad Shahid, Haleema Ali, Rasool Khan, Najeebullah Shamezai, Naveed Sharif
Evaluation of the Ameliorative Potential of 3,5- bis (2-hydroxyethyl)-1,3,5-thiadiazinane-2-thione against Scopolamine-Induced Alzheimer's Disease. International journal of molecular sciences 25 (16) (2024)
Hajra Afeera Hameed, Shahzeb Khan, Muhammad Shahid, Riaz Ullah, Ahmed Bari, Syed Saeed Ali, Zahid Hussain, Muhammad Sohail, Shafi Ullah Khan, Thet-Thet Htar
Engineering of Naproxen Loaded Polymer Hybrid Enteric Microspheres for Modified Release Tablets: Development, Characterization, in silico Modelling and in vivo Evaluation. Drug design, development and therapy 14 (2020)
Ashfaq Ahmad, Farhat Ullah, Abdul Sadiq, Muhammad Ayaz, Muhammad Saeed Jan, Muhammad Shahid, Abdul Wadood, Fawad Mahmood, Umer Rashid, Riaz Ullah, Muhammad Umar Khayam Sahibzada, Ali S Alqahtani, Hafiz Majid Mahmood
Comparative Cholinesterase, α-Glucosidase Inhibitory, Antioxidant, Molecular Docking, and Kinetic Studies on Potent Succinimide Derivatives. Drug design, development and therapy 14 (2020)
Muhammad Shahid, Fazal Subhan, Nazar Ul Islam, Nisar Ahmad, Umar Farooq, Sudhair Abbas, Shehla Akbar, Ihsan Ullah, Naila Raziq, Zia Ud Din
The antioxidant N-(2-mercaptopropionyl)-glycine (tiopronin) attenuates expression of neuropathic allodynia and hyperalgesia. Naunyn-Schmiedeberg's archives of pharmacology 394 (4) (2020)